cardiovascular-agents and Eye-Diseases

Topics: Arteriosclerosis; Cardiovascular Agents; Cardiovascular Diseases; Embolism; Endocarditis, Bacterial; Eye Diseases; Giant Cell Arteritis; Humans; Medical History Taking; Ocular Hypertension; Retinal Vein Occlusion; Syndrome

The treatment for asthma usually involves a combination of drugs used for bronchodilation and to treat underlying airway inflammation. When asthma is severe, the regimen used to treat asthma can become quite complicated, often using as many as 3 or 4 separate pharmacological agents. As patients with asthma get older, their medication regimen can become even more complex with the development of numerous other age-related diseases requiring their own list of medications. Diseases of the joints, diseases of the eye, cardiovascular disease, neurological disease and urological problems represent the most common conditions that patients develop, at times needing medications which might interfere with asthma management. Many of these diseases require the use of nonsteroidal anti-inflammatory agents, well known to provoke wheezing in patients with intrinsic asthma, and diseases of the eye and cardiovascular system frequently require use of beta-blockers which can cause or exacerbate asthma. Managing patients with asthma who have other diseases requires constant supervision of their medication usage and careful and cautious review of the entire list of medications at each presentation.

Topics: Adrenergic beta-Antagonists; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bone Diseases; Cardiovascular Agents; Cardiovascular Diseases; Eye Diseases; Humans

To verify, whether drugs used to treat hypertension, coronary disease, and heart insufficiency modify the hemodynamic effects of the combinations alfentanil-vecuronium and alfentanil-pancuronium, 36 patients taking these drugs (most often beta-adrenergic antagonists) were randomized to receive either vecuronium or pancuronium in connection with ophthalmic surgery. In comparison with healthy patients, the heart rate and arterial pressure changes during induction, intubation and surgery appeared to be smoothed. Heart rate and arterial pressure equaled between the study groups, indicating a block of the sympathomimetic actions of pancuronium. One third of the patients receiving vecuronium exhibited nodal rhythm and some of them showed slow heart rates during intense surgical stimulation. Pancuronium offered protection against bradyarrhythmias.

Topics: Aged; Alfentanil; Blood Pressure; Cardiovascular Agents; Drug Interactions; Eye Diseases; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pancuronium; Vecuronium Bromide

Topics: Anesthetics, Local; Cardiovascular Agents; Drug Therapy; Eye Diseases; Humans; Ophthalmology; Procaine

Topics: Cardiovascular Agents; Drug-Related Side Effects and Adverse Reactions; Electroretinography; Eye Diseases; Humans; Quinine; Toxicology

Topics: Cardiovascular Agents; Drug-Related Side Effects and Adverse Reactions; Eye; Eye Diseases; Humans; Quinine

Topics: Cardiovascular Agents; Ergot Alkaloids; Eye Diseases; Ophthalmologic Surgical Procedures; Ophthalmology

Topics: Cardiovascular Agents; Eye Diseases; Guaifenesin; Humans; Muscle Relaxants, Central

Topics: Cardiovascular Agents; Drug-Related Side Effects and Adverse Reactions; Eye; Eye Diseases; Humans; Quinine